<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00491920</url>
  </required_header>
  <id_info>
    <org_study_id>2006-003186-14</org_study_id>
    <nct_id>NCT00491920</nct_id>
  </id_info>
  <brief_title>High Dosage Vitamin D and Osteoporosis</brief_title>
  <official_title>High Dosage Vitamin D in the Treatment of Osteoporosis in Postmenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norske Kvinners Sanitetsforening Troms</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of North Norway</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D and calcium are essential in the treatment and prevention of osteoporosis. What
      dosage of vitamin D which is the ideal one, is not yet clear. We want to test the hypothesis
      that high dosage of vitamin D (i.e. 6500 IU/d) is better than standard dosage (800 IU/d) in a
      randomized double-blind trial. We will include 400 postmenopausal otherwise healthy women
      with T-score &lt;= -2.0 in L2-4 or mean total hip. Everybody will receive calcium 1000 mg and
      vitamin D 800 IU every day. Half of the group will also receive vitamin D 40 000 IU/week,
      while the other half will have placebo. The study period is one year.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in bone mineral density in columna and total hip.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (hand grip strength and knee extension)</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>balance (tandem test)</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition (Dexa)</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammation markers</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium and vitamin D metabolism</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lipids</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal function</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>telomere length</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perception of own health</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary tract symptoms</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effects of polymorphisms in VDR on the other endpoints</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">297</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Osteopenia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cholecalciferol (Vitamin D3)</intervention_name>
    <description>20 000 Iu x2/week
+ calcium 500 mg/cholecalciferol 400 IU x2/d</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Calcium 500 mg/Cholecalciferol 400 IU x2/d and placebo 2/w</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bone mineral density in L2-4 or mean total hip with T-score &lt;= -2.0

        Exclusion Criteria:

          -  current use of bisphosphonates, PTH-analogs, estrogen, SERM, p.o. steroids or use of
             any of these agents last year

          -  serum creatinin &gt;110 umol/L

          -  systolic blood pressure &gt;175 mmHg or diastolic blod pressure &gt;105

          -  serious disease (heart failure, angina pectoris, myocardial infarction, diabetes,
             mental reduction, granulomatous disease like sarcoidosis, cancer)

          -  kidney stone

          -  serum calcium &gt; 2.55 mmol/L

          -  suspect primary hyperparathyroidism with serum calcium &gt;2.50 mmol/L combined with PTH
             &gt; 5.0 mmol/L or serum calcium &gt; 2.45 mmol/L combined with PTH &gt;= 7.0 pmol/L
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rolf Jorde, Ph.D, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Dpt, University Hospital of Northern Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Dpt. B, University Hospital of Northern Norway</name>
      <address>
        <city>Troms√∏</city>
        <zip>9012</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2007</study_first_submitted>
  <study_first_submitted_qc>June 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2007</study_first_posted>
  <last_update_submitted>November 2, 2011</last_update_submitted>
  <last_update_submitted_qc>November 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteoporosis</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

